HORIBA is at the forefront of advancing next-generation biotherapeutics and pharmaceuticals. From Raman-based protein secondary structure analysis to the rapid infectious titer determination through simultaneous multi-laser Nanoparticle Tracking Analysis, and the A-TEEM fluorescence method for AAV characterization and vaccine batch release, HORIBA provides indispensable insights that matter across the entire biotherapeutic journey, from development to manufacturing. In the small molecule arena, HORIBA's comprehensive portfolio of analytical instruments, encompassing cutting-edge Raman microscopy and a full range of particle sizing techniques, accelerates product development, addresses critical troubleshooting questions, and excels in contaminant identification.